CLINICAL_TRIALS
trial_result
· 2021-05-10
Clinical Trial Update: An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension [Phase 3]
Summary
Open-label extension trial of UT-15C sustained-release in pulmonary arterial hypertension completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2021-05-10